How do your donations accelerate research for a cure and improve the lives of people affected by MS?
Your generosity supports ACP’s initiatives to accelerate MS research for quicker diagnosis, more effective treatments, and a cure for all living with the disease.
ACP is collaborating with Biostate AI to develop advanced AI models that use RNA data to anticipate the course of MS and how patients may respond to treatment.
Biostate AI is a recognized leader in using artificial intelligence (AI) to analyze RNA, helping researchers better understand how diseases develop and progress.
As part of the partnership, Biostate will analyze all ACP Repository samples and develop AI models to address various research and clinical questions, focusing on improving predictions of MS progression and identifying patients who will benefit most from treatments.
This effort strengthens ACP’s commitment to accelerating cures via collaboration, data sharing, and cutting-edge research, while giving Biostate the opportunity to apply its AI tools to areas where better treatments are urgently needed.
The ACP Repository is an open-access resource of blood samples and data for studying MS and similar diseases. Researchers must return their findings to the database to support future studies.
“Biostate’s RNA sequencing and AI technologies offer a unique opportunity to transform our understanding of MS progression and treatment response. We are thrilled to collaborate with Biostate AI to unlock the full potential of our biorepository and accelerate innovations leading to better outcomes for people with MS.” – Sara Loud
